2251 GMT - Healius could return some A$300 million to its shareholders from selling its imaging business Lumus, reckons Citi. Healius in September said it would sell Lumus to Affinity Equity Partners for A$965 million, but didn't specify how much of the proceeds would be returned to shareholders. Analyst Mathieu Chevrier thinks it could involve Healius declaring a special dividend of A$0.40/share. "We upgrade to Neutral on recent share price decline, sale of Lumus which will make Healius debt-free, and a pathology cost base now likely more reflective of true business-as-usual costs," Citi says. (david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
November 19, 2024 17:52 ET (22:52 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.